Pharmacological therapeutic alternatives for binge eating disorder: a systematic review
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.438Keywords:
binge eating, pharmacology, therapyAbstract
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder, an eating disorder characterized by repetitive episodes of uncontrollably consuming abnormally large amounts of food without inappropriate weight loss behaviors. Therefore, this study aimed to evaluate the effectiveness of pharmacological therapeutic alternatives in the treatment of binge eating disorder. Thus, a systematic review was carried out from the selection of scientific studies published in the years 2017 to 2022. Based on the analysis and interpretation of the data, it was concluded that pharmacological therapeutic alternatives are complementary resources both in the treatment of binge eating disorder as symptoms of an eating disorder and not surrogates. In this sense, the use of drugs such as fluoxetine, lisdexamfetamine and simplicifolia, combined with other treatments, such as psychotherapy, can be effective for patients and their specific needs.
Downloads
Metrics
References
Cauduro GN, Pacheco JTB, Paz GM. Avaliação e intervenção no transtorno da compulsão alimentar (tca): uma revisão sistemática. Psico. 2018;49(4):384-394. https://doi.org/10.15448/1980-8623.2018.4.28385
Hayes SC, Hofmann SG. Terapia cognitivo-comportamental baseada em processos: ciência e competências clínicas. Porto Alegre: Artmed; 2020.
Assis LV, Morais ACS, Meireles IS, Costa LF, Guerra MLA, Novaes MVG, Rêgo RCL. Obesidade: diagnóstico e tratamento farmacológico com Liraglutida, integrado a terapia comportamental e mudanças no estilo de vida. REAS. 2021;13(5):e6830-e6830. https://doi.org/10.25248/reas.e6830.2021
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington: American Psychiatric Publishing; 2013.
Hiluy J, Nunes FT, Pedrosa MAA, Appolinario JC. Os transtornos alimentares nos sistemas classificatórios atuais: DSM-5 e CID-11. Debates em Psiquiatria. 2019;9(3):6-13. https://doi.org/10.25118/2763-9037.2019.v9.49
Bloc LG, Nazareth ACP, Melo AKS, Moreira V. Transtorno de compulsão alimentar: revisão sistemática da literatura. Revista Psicologia e Saúde. 2019;11(1):3-17. https://doi.org/10.20435/pssa.v11i1.617
Soares RM. Trajetórias de vida de pessoas com obesidade residentes em São Paulo: vulnerabilidades e marcadores sociais da diferença. [Tese de Doutorado]. São Paulo: Universidade de São Paulo; 2021. https://doi.org/10.11606/T.5.2021.tde-16082021-121645
Timerman, F. Transtornos alimentares. São Paulo: Senac; 2021.
Alves, N. S. Estudo caso-controle: SNP rs6277 do gene DRD2 da dopamina na obesidade pediátrica. São Paulo: Dialética; 2022. https://doi.org/10.48021/978-65-252-5854-6
Azevedo DCS. Farmácia Trofense, Trofa e Serviços Farmacêuticos do Hospital Pedro Hispano. Unidade Local de Saúde de Matosinhos, EPE, Matosinhos. [Relatório de Estágio]. Porto: Universidade do Porto; 2021. https://hdl.handle.net/10216/144067
Himmerich H, Treasure J. Psychopharmacological advances in eating disorders. Expert Rev Clin Pharmacol. 2017; 11(1):95-108. https://doi.org/10.1080/17512433.2018.1383895 - PMid:28933969
Silva LS, Silva CC. A utilização da Griffonia Simplicifolia e Rhodiola Rosea L. em mulheres obesas com compulsão alimentar. Revista Brasileira De Obesidade, Nutrição e Emagrecimento. 2018;12(70):265-274. http://www.rbone.com.br/index.php/rbone/article/view/691
Mattos CN. Ensaio clínico duplo-cego, randomizado, controlado com placebo, de duração de 12 semanas, para avaliar eficácia, tolerabilidade e segurança do topiramato na oniomania. [Tese de Doutorado]. São Paulo: Universidade de São Paulo; 2019. https://doi.org/10.11606/T.5.2019.tde-07082019-091122
Quilty LC, Allen TA, Davis C, Knyahnytska Y, Kaplan AS. A randomized comparison of long acting methylphenidate and cognitive behavioural therapy in the treatment of binge eating disorder. Psychiatry Res. 2019;273:467- 474. https://doi.org/10.1016/j.psychres.2019.01.066 - PMid:30684794
Peterson CB, Mitchell JE. Psychosocial and pharmacological treatment of eating disorders: a review of research findings. J Clin Psychol. 2019;55(6):685-697. https://doi.org/10.1002/(SICI)1097-4679(199906)55:6<685::AID-JCLP3>3.0.CO;2-Y
Araújo DA. Práticas integrativas e complementares no tratamento da obesidade. 2021. 20f. [Trabalho de Conclusão de Curso]. Goiânia: Universidade Católica de Goiás; 2021. https://repositorio.pucgoias.edu.br/jspui/bitstream/123456789/1783/1/Pr%C3%A1ticas%20Integrativas%20e%20Complementares%20no%20tratamento%20da%20obesidade%20%283%29.pdf
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2023 Natália de Oliveira Ferrarini , Izabely Lima Assunção, Márcia Andréa Silva Carvalho Sombra, Renata Reis Frizon, Vitor Hugo Gomes Araújo, Onassis Boeri de Castro, Jadhe Cristina Martins Segato
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
